BindingDB logo
myBDB logout

20 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27818110 61 Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacology.EBI Merck Research Laboratories
21831639 32 Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders.EBI Glaxosmithkline
24737316 18 Structural basis of pharmacological chaperoning for human ß-galactosidase.BDB The University of Tokyo
11809867 38 A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study.BDB University of Ferrara
12573694 13 Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation.BDB Tohoku University
19054673 66 5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.BDB Anadys Pharmaceuticals
19267475 118 Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins.BDB Sapienza University of Rome
18620380 8 Selectivity determinants of inhibitor binding to human 20alpha-hydroxysteroid dehydrogenase: crystal structure of the enzyme in ternary complex with coenzyme and the potent inhibitor 3,5-dichlorosalicylic acid.BDB Monash University
18579385 132 Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid.BDB Universita Degli Studi Di Firenze
18621524 17 The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase.BDB Gsk
8464047 14 Cyclic sulfolanes as novel and high affinity P2 ligands for HIV-1 protease inhibitors.BDB Merck Research Laboratories